Bausch Health Companies Inc. (BHC) insider trading

By person

42 insiders · 97 transactions

13.1×

Thomas J. Appio holds 13.1 times base salary in stock. $16.28M of shares against $1.24M in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas J. Appio last reported holding, valued at $7.03, the price Common Shares, No Par Value was last bought or sold at on the open market here, on 19 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

John Paulson

Director

$566.66M (22)

$113.78M (2)

+$452.88M

144,452,700

38.62%

$1.02B

+51.0%

Pershing Square Capital Management, L.P. entity

See footnote (3)

—

$250.89M (2)

−$250.89M

0.0000%

$0.00

−100.0%

ValueAct Holdings, L.P. entity

Director

$50.71M (3)

$18.25M (1)

+$32.47M

17,931,594

4.79%

$126.06M

+19.2%

Paulson & Co. Inc. entity

10% owner

$15.63M (1)

—

+$15.63M

73,255,869

19.59%

$514.99M

+3.5%

Schutter Richard U De

Director

$4.80M (12)

—

+$4.80M

387,207

0.1035%

$2.72M

+10,668%

Christina Ackermann

EVP and General Counsel

$80.11K (1)

$4.53M (5) scheduled

−$4.45M

162,240

0.0434%

$1.14M

+172.3%

Joseph C Papa

Director

$2.56M (4)

—

+$2.56M

1,427,568

0.3817%

$10.04M

+148.1%

William D. Humphries

President, Ortho-Dermatologics

$650.14K (1)

$3.08M (5) scheduled

−$2.43M

235,035

0.0628%

$1.65M

—

Steven D Miller

Director

$1.45M (2)

—

+$1.45M

239,224

0.0640%

$1.68M

+239,124%

Paul Herendeen

EVP and CFO

$724.85K (3)

—

+$724.85K

386,618

0.1034%

$2.72M

+157.7%

Thomas Appio

Chief Executive Officer

$584.02K (1)

—

+$584.02K

2,315,374

0.6191%

$16.28M

+10,765%

Sam Eldessouky

EVP & Chief Financial Officer

—

$538.59K (1)

−$538.59K

119,455

0.0319%

$839.77K

+122.1%

Joseph F Gordon

Pres&Co-Head Bausch&Lomb/Int'l

—

$494.47K (3)

−$494.47K

93,139

0.0249%

$654.77K

+130.6%

Seana Carson

EVP, General Counsel

—

$421.37K (14) scheduled

−$421.37K

616,761

0.1649%

$4.34M

+799.5%

Amy B Wechsler

Director

—

$350.81K (1)

−$350.81K

316,158

0.0845%

$2.22M

+1,700%

Robert Spurr

President, U.S. Businesses

—

$348.16K (5)

−$348.16K

112,741

0.0301%

$792.57K

+180.1%

Aimee J. Lenar

President, US Pharma

—

$258.89K (1) scheduled

−$258.89K

334,853

0.0895%

$2.35M

—

Frank D. Lee

Director

—

$254.68K (2) scheduled

−$254.68K

95,210

0.0255%

$669.33K

—

Mark C. McKenna

President, Salix

—

$235.22K (1)

−$235.22K

20,756

0.0055%

$145.91K

−1.8%

Thomas W. Ross Sr.

Director

$112.49K (2)

—

+$112.49K

161,516

0.0432%

$1.14M

+654.1%

Eschenbach Andrew C. Von

Director

$56.31K (2)

—

+$56.31K

38,647

0.0103%

$271.69K

+3,765%

David Robert Hale

Director

—

18,908,638

5.06%

$132.93M

+0.3%

Jean-Jacques Charhon

EVP, CFO

—

706,478

0.1889%

$4.97M

—

Ari Kellen

EVP, Company Group Chairman

—

630,842

0.1687%

$4.43M

−3.1%

Tom George Vadaketh

EVP, Chief Financial Officer

—

564,933

0.1511%

$3.97M

+455.9%

Robert L. Rosiello

EVP, Corp Dev & Strategy

—

517,683

0.1384%

$3.64M

−2.8%

Robert N Power

Director

—

300,594

0.0804%

$2.11M

+827.2%

Sarah B Kavanagh

Director

—

282,230

0.0755%

$1.98M

+1,908%

Russel C Robertson

Director

—

225,279

0.0602%

$1.58M

+1,208%

Brett Icahn

Director

—

220,280

0.0589%

$1.55M

—

John S Barresi

SVP, Controller & CAO

—

192,268

0.0514%

$1.35M

—

Anne Clem Whitaker

EVP, Company Group Chairman

—

158,885

0.0425%

$1.12M

−3.9%

Richard Mulligan

Director

—

155,616

0.0416%

$1.09M

+340.1%

Christian A Garcia

Director

—

135,578

0.0363%

$953.11K

—

Argeris N Karabelas

Director

—

123,715

0.0331%

$869.72K

+508.8%

Sandra Leung

Director

—

102,859

0.0275%

$723.10K

—

Robert Alexander Ingram

Director

—

92,046

0.0246%

$647.08K

+4.1%

Michael Goettler

Director

—

76,020

0.0203%

$534.42K

—

Steven Hyosig Lee

SVP, Controller & CAO

—

70,114

0.0187%

$492.90K

—

Eiry Roberts

Director

—

45,871

0.0123%

$322.47K

—

Fredric N Eshelman

Director

—

38,298

0.0102%

$269.23K

+115.2%

Frederick Munsch

SVP, Controller and CAO

—

22,435

0.0060%

$157.72K

+6.0%

Bausch Health Companies Inc.

What the insiders did Net buying

By person